Assignee
GENAISSANCE PHARMACEUTICALS
US·10 granted patents·13 pending applications·536 citations·filing 1997–2005
Top patents by PatentIndex Score
23 records- 0194US6931326B1Methods for obtaining and using haplotype dataGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Aug 16, 2005·136 cites·37 claims
- 0292US7058517B1Methods for obtaining and using haplotype dataGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Jun 6, 2006·161 cites·4 claims
- 0386US6521747B2Haplotypes of the AGTR1 geneGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Feb 18, 2003·59 cites·32 claims
- 0485US6232076B1Stabilizer of dye sequencing productsGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted May 15, 2001·22 cites·21 claims
- 0584US6797477B2Genetic typing of the human cytochrome P450 2A6 gene and related methodsGENAISSANCE PHARMACEUTICALS·Filed 2002·Granted Sep 28, 2004·10 cites·10 claims
- 0680US6797472B1Variation in drug response related to polymorphisms in β2-adrenergic receptorGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Sep 28, 2004·7 cites·4 claims
- 0779US6586183B2Association of β2-adrenergic receptor haplotypes with drug responseGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Jul 1, 2003·13 cites·10 claims
- 0878US6944767B1Methods and apparatus for ensuring the privacy and security of personal medical informationGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Sep 13, 2005·34 cites·9 claims
- 0978US5972614AGenome anthologies for harvesting gene variantsGENAISSANCE PHARMACEUTICALS·Filed 1997·Granted Oct 26, 1999·80 cites·4 claims
- 1055US6861217B1Variation in drug response related to polymorphisms in the β2-adrenergic receptorGENAISSANCE PHARMACEUTICALS·Filed 1999·Granted Mar 1, 2005·14 cites·2 claims
- 1148US2005255495A1SLC5A7 genetic markers associated with age of onset of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1247US2006166219A1NTRK1 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1347US2005250122A1APOA4 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1447US2005255492A1CHRNA9 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1547US2005260613A1LRPAP1 genetic markers associated with galantamineGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1647US2005250118A1EPHX2 Genetic markers associated with galantamineGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1747US2005250121A1NTRK2 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1847US2005255488A1NTRK1 genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1941US2003165844A1Haplotypes of the TNFRSF1A geneGENAISSANCE PHARMACEUTICALS·Filed 2001·Application pending·0 cites
- 2037US2006154265A1LDLR genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2137US2005277129A1APOE genetic markers associated with age of onset of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2237US2005255498A1APOC1 genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2336US2008020383A1Haplotype Markers And Methods Of Using The Same To Determine Response To TreatmentGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENAISSANCE PHARMACEUTICALS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →